US EditionPublished • loading... • Updated
FDA warns websites selling unapproved Botox for cosmetic purposes
The FDA issued warnings to 18 websites selling unapproved Botox, citing serious health risks including botulism; 22 cases with 11 hospitalizations were reported across 11 states, officials said.
- The FDA issued 18 warning letters to websites illegally marketing unapproved and misbranded botulinum toxin products, commonly called Botox, for cosmetic purposes.
- Botulinum toxin products carry serious health risks, including botulism symptoms, and can only be used with a prescription from a licensed healthcare professional.
- Consumers should only receive FDA-approved botulinum toxin products from authorized sources to avoid dangerous counterfeit or contaminated products.
Insights by Ground AI
Podcasts & Opinions
41 Articles
41 Articles
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and other similar injectable drugs commonly used to smooth wrinkles.
Coverage Details
Total News Sources41
Leaning Left13Leaning Right5Center19Last UpdatedBias Distribution51% Center
Bias Distribution
- 51% of the sources are Center
51% Center
L 35%
C 51%
14%
Factuality
To view factuality data please Upgrade to Premium
